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Abstract
IZUMO is a surface protein on sperm and essential for egg fusion in mice. To investigate the possible associa-
tion between variations in the IZUMO gene and impaired spermatogenesis in Japanese males, we screened for muta-
tions in the human IZUMO gene using DNA from 892 sterile male patients and 172 proven-fertile male volunteers.
Single Nucleotide Polymorphisms (SNPs) were identified in the heterozygous state in the infertile patients, and nei-
ther variant was identified in fertile subjects using an ABI-PRISM 3730xl Genetic Analyzer and SeqScape software
(Applied Biosystems). Four single nucleotide polymorphisms (SNPs), 417T>G (Cys139Trp), 589A>T (Ser197Cys),
939T>A (Phe313Leu), and 944G>A (Arg315Gln), were found significantly more often in infertile subjects than in
fertile controls in the first screening. Otherwise, the four SNPs were not detected by direct sequencing using the other
primers. These results show that four SNPs exist as an analytical target of SNPs that associated with the male infertil-
ity in the IZUMO gene.
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１．Introduction
Infertility affects approximately 15% of cou-
ples, and in about half of those cases, the problem
resides with the male１）. The development of novel
fertilization treatments, including in vitro fertiliza-
tion and intracytoplasmic injection, has made preg-
nancy possible regardless of the level of spermato-
zoa activity, but the etiology of male-factor infertil-
ity remains unclear.
Fertilization includes a series of cellular inter-
actions, and infertility might be caused by dysfunc-
tions of the molecules that are engaged in the fusion
between the reacted spermatozoa and the mature oo-
cyte. Two ADAM proteins present on sperm were
considered as candidates for sperm-egg fusion but
deleting the gene in mice showed that fusion still oc-
curred and that these genes were dispensable２）. In
contrast, IZUMO is the only molecule indispensable
for sperm-egg fusion because mouse sperm lacking
Izumo are unable to fuse２）. IZUMO was identified
through the generation of a monoclonal antibody
that inhibits sperm-egg fusion３）. The expression of
Izumo is specific to testis and the protein is localized
in an acrosomal region exposed on the surface only
after the acrosome reaction occurs. IZUMO protein
is a typical type-1 membrane glycoprotein with one
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immunoglobulin-like domain and one N-glycoside
link motif４）. Izumo -/- male mice are healthy and pro-
duce normal-like sperm that bind to and penetrate
the zona pellucida but are incapable of fusing with
eggs５）. From these results, IZUMO appears to be in-
volved in sperm-egg fusion; thus, IZUMO dysfunc-
tion may be associated with human male infertility.
We examined single nucleotide polymorphisms
(SNPs) as a cause of male infertility in an analysis
of genes expressed specifically in spermatogenesis
６-９）
. In the present study, we assessed the prevalence
of SNPs in the IZUMO coding region by directly
sequencing PCR-amplified DNA from male patients
who developed azoospermia or severe oligospermia.
In total, 1064 DNA samples were analyzed: 892
from infertile patients and 172 from proven-fertile
volunteers. Twenty-five variation-induced amino
acid substitutions were found in the coding region of
IZUMO , and the other one was silent. One SNP in
the fifth exon, one SNP in the seventh exon, and two
SNPs in the tenth exon accumulated significantly in
infertile patients. Although the necessity for solving
the problem of the primer design has been left, the
SNPs associated with the male infertility might exit
in the IZUMO gene.
２．Materials and Methods
2.1 Participants
Japanese subjects with non-obstructive infertil-
ity (n = 892) were assigned to five subgroups: azoo-
spermia (28.4%), oligozoospermia (count < 20 mil-
lion cells/mL; 26.6%), asthenospermia (count > 20
million cells/mL and motility < 50%; 26.6%), tera-
tozoospermia (abnormality > 85%; 0.4%), and nor-
mal (18.0%), according to World Health Organiza-
tion criteria１０）. All patients displayed idiopathic in-
fertility and had no history of prior medical condi-
tions, including but not limited to cryptorchidism,
recurrent infections, trauma, orchitis, or varicocele.
All subjects were identified with primary idiopathic
infertility based on a cytogenetic analysis. The con-
trol group consisted of fertile males who had fa-
thered children born at a maternity clinic (n = 172).
All of the donors were informed of the purpose of
Table１ The region amplified by PCR and sequeincing primers for the IZUMO gene.
Exons/Introns Location
Primers
Name Sequence 5’-3 Position of 5’
EXON2 -72～235 1 GGTTTGCGGACCCCATGGATAGGC -144
EXON3 572～646 2r GGGTCCACAGCCTAGTATCTGACC 740
EXON4 1321～1407 3 GCATTGCCTAGCCCAGCAGCTGGC 1169
EXON5 1665～1685 4r AGTGGGGAGGTTGACTATTCAGAG 1746
EXON6 2335～2415 5.1 GTTGGAGCCCACTTACTACTTACC 2176
EXON7 3551～3651 6.1r GAGACCACACCTAATAGACCACCC 3772
EXON8 3918～4071 7 ACACTCACCTCCCACACTGAGGCC 3817
EXON9 4382～4559 9.5r CCGCCCCTTACTCCAAGCCAAGCC 4607
EXON10 4832～4972
9.8 ATAGGAGGACTTCGAAGGGCGAGG 4698
8r GGGACAGATGGGAAGCAGGTGTGC 5770
EXON5 1665～1685
S417F* AGAAATCTGACTCTGTCATCTCTTTCTTGCTCTC 1610
S417R* GAGGTTGACTATTCAGAGGGCAGGATG 1740
EXON7 3551～3651
S589F* CCTGGACTGTGAGTTAAACTGGCATCA 3588
S589R* AGTTCAAGGGTTACAGAAGTTGAGGCC 3683
EXON10 4832～4972
S939F* CCAAACCGGTTCCATGATCTGCA 4791
S939R* CCAAGGCCAAACAGTGAGGATTTGA 4888
The position for each primer is that of the first nucleotide in relation to the first nucleotide of the ATG start codon.
*Primers for double-check of sequences
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the study and gave permission for their blood and
semen to be used for genomic DNA analysis. This
study was carried out with the approval of the insti-
tutional review board, independent ethics committee
in Osaka University.
2.2 Identification of SNPs in IZUMO by the Direct
Sequencing of PCR-Amplified DNA
DNA samples of proven-fertile (n = 172) and
some of the infertile patients (n = 247) were ex-
tracted from blood leukocytes. DNA samples from
the remainder of the infertile patients (n = 645) were
extracted from cells in semen. Genomic DNA was
isolated from the blood samples using standard pro-
tease treatment and phenol extraction procedures.
Genomic DNA from sperm was isolated as follows.
Freeze-stocked semen (1 mL) was dissolved and
added to 1 mL phosphate-buffered saline (PBS). The
samples were centrifuged at 10,000 rpm for 10 min
at 4°C. The precipitate was used for the extraction of
genomic DNA using QuickGene-800 (Fujifilm, To-
kyo, Japan) according to the manufacturer’s instruc-
tions. The sequences containing the encoded region
in the 10 exons of the IZUMO gene were amplified
by PCR using specific primers (Table 1) under the
conditions described in table 2.
The PCR-amplified fragments were purified
using AMPure (Agencourt Bioscience Corporation,
Beverly, MA) and then sequenced using the same
PCR primers with the BigDye Terminator v3.1 Cy-
cle Sequencing Kit (Applied Biosystems, Foster
City, CA). The reaction products were purified by
the BigDye XTerminator and analyzed using an
ABI-PRISM 3730xl Genetic Analyzer (Applied
Biosystems). Any subjects with sequence ambigui-
ties were excluded. The screening of variations in
the sequences was performed with SeqScape soft-
ware (Applied Biosystems).
2.3 Statistical Analysis
The X２-test was used to compare the genotype
distribution between infertile subjects and proven-
Table２ Conditions of PCR for SNPs analyses
Region Primers Denatureing
temp. and time
Annealing temp.
and time
Extension time
and cycle number
Product size
(bp)
EXON 2, 3 12r 98, 10sec 67, 5sec
72, 150sec*
40cycles 884
EXON 4, 5 34r 96, 30sec 62, 30sec
72, 150sec**
40cycles 578
EXON 6, 7 5.16.1r 96, 30sec 65, 30sec
72, 150sec**
40cycles 1597
EXON 8, 9 79.5r 96, 30sec 67, 30sec
72, 150sec**
40cycles 791
EXON 10 9.88r 96, 30sec 64, 30sec
72, 150sec**
40cycles 1073
417T>G S417FS417R 95, 30sec 68, 30sec
72, 150sec***
35cycles 131
589A>T S589FS589R 95, 30sec 68, 30sec
72, 150sec***
35cycles 103
939T>A
944G>A
S939F
S939R 95, 5sec 68, 40sec
72, 150sec**
35cycles 99
*PrimeSTAR
**Ex TaqHS
***Go TaqHS
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Table３ The identified variants. positions and genotypes in infertile male and controls
Region Position Genotype Number (%) of SNP P value ReferenceNCBI dpSNP #Nucleotide Amino acid Infertile Proven fertile
Exon 2 32 Ala11 C/C 771 (99.9) 172 (100)
Ala11[Ala, Glu] C/A 1 (0.1) 0 (0) 0.637
38 Ala13 C/C 768 (99.5) 172 (100)
Ala13[Ala, Asp] C/A 4 (0.5) 0 (0) 0.344
41 Gly14 G/G 772 (99.9) 172 (100)
Gly14[Gly, Asp] G/A 1 (0.1) 0 (0) 0.637
115 Asp39 G/G 773 (99.9) 172 (100)
Asp39[Asp, Asn] G/A 1 (0.1) 0 (0) 0.637
157 Met53 A/A 773 (99.9) 172 (100)
Met53Val G/G 1 (0.1) 0 (0) 0.637
169 Val57 G/G 773 (99.9) 172 (100)
Val57[Val, Ile] G/A 1 (0.1) 0 (0) 0.637
214 Asp72 G/G 774 (99.9) 172 (100)
Asp72[Asp, Asn] G/A 1 (0.1) 0 (0) 0.637
Exon 3 285 Lys95 A/A 732 (99.9) 172 (100)
Lys95[Lys, Asn] A/T 1 (0.1) 0 (0) 0.628
Exon 4 321 Phe107 C/C 17 (2.4) 2 (1.2) 0.314 rs8108468
- C/T 140 (19.8) 31 (18.3) 0.616
- T/T 550 (77.8) 136 (80.5)
C/C+C/T 157 (22.2) 33 (19.5) 0.448
Exon 5 407 Pro136 C/C 410 (99.5) 169 (100)
Pro136[Pro, Leu] C/T 2 (0.5) 0 (0) 0.364
409 Asn137 A/A 383 (99.2) 169 (100)
Asn137[Asn, His] A/C 3 (0.8) 0 (0) 0.250
417 Cys139 T/T 347 (92.8) 169 (100)
Cys139[Cys, Trp] T/G 27 (7.2) 0 (0) <0.001
Exon 6 442 Trp148 T/T 351 (997) 170 (100)
Trp149[Trp, Arg] T/A 1 (0.3) 0 (0) 0.487
445 Cys149 T/T 351 (99.7) 170 (100)
Cys149[Cys, Gly] T/G 1 (0.3) 0 (0) 0.487
497 Gly166 G/G 350 (99.7) 170 (100)
Gly166[Gly, Glu] G/A 1 (0.3) 0 (0) 0.486
Exon 7 577 Leu193 C/C 352 (99.7) 167 (100)
Leu193[Leu, Phe] C/T 1 (0.3) 0 (0) 0.491
589 Ser197 A/A 302 (92.1) 167 (100)
Ser197[Ser, Cys] A/T 26 (7.9) 0 (0) <0.001
Exon 8 719 Ser240 C/C 120 (99.2) 158 (100)
Ser240[Ser, Phe] C/T 1 (0.8) 0 (0) 0.252
Exon 10 937 Phe313 T/T 315 (99.7) 168 (100)
Phe313[Phe, Ile] T/A 1 (0.3) 0 (0) 0.489
939 Phe313 T/T 297 (93.7) 168 (100)
Phe313[Phe, Leu] T/A 20 (6.3) 0 (0) <0.001
944 Arg315 G/G 296 (92.5) 168 (100)
Arg315[Arg, Gln] G/A 24 (7.5) 0 (0) <0.001
947 Arg316 G/G 320 (99.4) 162 (96.4)
Arg316[Arg, Lys] G/A 2 (0.6) 6 (3.6) 0.014
953 Val318 T/T 326 (99.7) 168 (100)
Val318[Val, Glu] T/A 1 (0.3) 0 (0) 0.473
998 Val333 T/T 263 (79.7) 138 (82.1) rs2307019
Val333[Val, Ala] T/C 55 (16.7) 28 (16.7) 0.906
Val333Ala C/C 12 (3.6) 2 (1.2) 0.117
C/C+T/C 67 (20.3) 30 (17.9) 0.515
999 Val333[Val, Ala] T/T 258 (78.2) 138 (82.1) rs2307018
Val333[Val, Ala] G/T 58 (17.6) 28 (16.7) 0.685
Val333[Val, Ala] G/G 14 (4.2) 2 (1.2) 0.064
G/G+G/T 72 (21.8) 30 (17.9) 0.300
1040 Ser347 C/C 332 (99.7) 168 (100)
Ser347[Ser, Ter] C/A 1 (0.3) 0 (0) 0.477
The translation start site was +1on IZIMO cDNA.
The whole population could not be fully determined due to the condition of some samples.
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fertile controls. A P-value of < 0.05 was considered
to be statistically significant.
３．Results
The entire coding sequence of IZUMO (EMBL
/DDBJ/GenBank Accession Number NC_000019,
53935957-53941978; IZUMO) and the intronic re-
gions adjacent to each exon were analyzed for se-
quence variations by direct sequencing as the first
screening, and 26 were found: seven variants in
exon 2, one variant in exon 3, 4, or 8, three variants
in exon 5 or 6, two variants in exon 7, and eight
variants in exon 10 (Table 3). The 21 variation-
induced amino acid substitutions at 32C>A (Ala11
Glu), 38C>A (Ala13Asp), 41G>A (Gly14Asp), 115
G>A (Asp39Asn), 169G>A (Val57Ile), 214G>A
(Asp72Asn), 285A>T (Lys95Asn), 407C>T (Pro
136Leu), 409A>C (Asn137His), 417T>G (Cys139
Trp), 442T>A (Trp148Arg), 445T>G (Cys149Gly),
497G>A (Gly166Glu), 577C>T (Leu193Phe), 589A
>T, (Ser197Cys), 719C>T (Ser240Phe), 937T>A
(Phe313Ile), 939T>A (Phe313Leu), 944G>A (Arg
315Gln), 953T>A (Val318Glu), and 1040C>A (Ser
347Ter) were either in the major homozygous or
heterozygous states; no minor homozygous SNPs
were identified. The one variation-induced amino
acid substitution at 157A>G (Met53Val) was either
the major or minor homozygous state; no heterozy-
gous SNPs were observed. These 22 variations were
not detected in any of the fertile subjects. The four
different sequence changes in these variations, 417T
>G, 589A>T, 939T>A, and 944G>A, were signifi-
cantly (P<0.001) more frequent in the heterozygous
state in the infertile subjects (Fig. 1). Because 939T
>A and 944G>A almost always occurred in the
same subjects, these two SNPs seemed to be linked.
The three known SNPs were observed in exon 4 (rs
8108468) and exon 10 (rs2307019 and rs2307018).
Because subjects showing the 998T>C homozygous
state were almost always the same as the subjects
showing the 999T>G homozygous state, these two
SNPs also seemed to be linked. The amino acids Ala
Figure１ Schematic view of the 6-kb IZUMO gene IZUMO mRNA (1,621 nucleotides), and the IZUMO pro-
tein (350 amino acids). Exons 1-10 are depicted as thick boxes, and the introns are shown as lines. Numbers (up-
per) indicate the positions of the exons. Four SNPs that accumulated significantly in infertile males were desig-
nated. Each SNP is named based on its position in relation to the first nucleotide of the start codon. Numbers
(lower) indicate the positions of the amino acids in relation to the first methionine (MET). SP, signal peptide; IG,
immunoglobulin-like domain; TM, transmembrane region.
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Figure２ Alignment of the putative amino acid sequences of humans, chimpanzees, cows, mice, and rats. Amino-acid iden-
tity is indicated by an asterisk. Amino acids indicated by arrows correspond to the SNP substitutions that accumulated signifi-
cantly in infertile subjects. Amino acids designated by an underline correspond to the other SNPs specific to infertile men. The
immunoglobulin-like domain is boxed. The putative transmembrane region is boxed in gray. The cysteine residues that might
form a disulfide bridge are indicated by open arrowheads. The asparagine residue, which is an N-glycosylation site, is indicated
by a closed arrowhead.
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13, Lys95, Pro136, Asn137, Cys139, Trp148, Cys
149, Gly166, Leu193, and Ser197 were conserved
in the IZUMO sequence (Fig. 2). Because a con-
served amino acid sequence within different species
means that the region has a common and important
function, these substitutions may influence activity
of IZUMO. However, the heterozygous variations
showing low significance might only be rare muta-
tions unrelated to IZUMO function. Otherwise, sig-
nificant variations, such as Cys139Trp and Ser197
Cys, might function as dominant-negative. IZUMO
may be involved in sperm-egg fusion; thus, it is pos-
sibly associated with human male infertility. There-
fore, variations that affect functioning of the IZUMO
gene would appear in the genome sequence in infer-
tile human males. The four variations inducing the
substitution of amino acids Cys139Trp, Ser197Cys,
Phe313Leu, and Arg315Gln were strongly associ-
ated with male infertility. No patient had these SNPs
more than once. The sperm of almost all patients
having these SNPs showed normal sperm count and
morphology (Table 4).
Additionally, we analyzed the 4 SNPs signifi-
cantly more frequent identified in the infertile sub-
jects by using the additional primer sets (Table 1).
These SNPs in figure 3 were not identified in each
two samples of 4 SNPs by additional primers.
４．Discussion
IZUMO is the sperm protein confirmed to be
essential for egg fusion in mice, and male infertile
patients may have mutations in the IZUMO gene. In
this study, we found several differences between in-
fertile subjects and fertile controls in genotypes that
Table４ The case of total infertile patients and the number (%) of the infertile patients having each SNP in the case
Case of infertility Number of a patient
Nucleic acid position of SNPs
４１７T>G ５８９A>T ９３９T>A ９４４G>A
Azoospermia ２５３ （２８．４） ０ （０） ０ （０） １ （５） １ （４．２）
Oligozoospermia ２３７ （２６．６） ５ （１８．５） ７ （２６．９） ５ （２５） １０ （４１．７）
Asthenospermia ２３７ （２６．６） ８ （２９．６） ６ （２３．１） ５ （２５） ４ （１６．７）
Teratozoospermia ４ （０．４） ０ （０） ０ （０） １ （５） １ （４．２）
Normal sperm １６１ （１８） １４ （５１．９） １３ （５０） ８ （４０） ８ （３３．３）
Total ８９２ （１００） ２７ （１００） ２６ （１００） ２０ （１００） ２４ （１００）
Figure３ Detection of SNPs in IZUMO gene. The four nucleic acid positions were distinctly identified as heterozygous
genotypes (arrows) by the first screenng. The translation start site was +1 on IZUMO cDNA.
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caused amino acid substitutions in the first screen-
ing. Heterozygous Cys139Trp, Ser197Cys, Phe313
Ile, and Arg315Gln accumulated significantly in in-
fertile patients and were strongly associated with
normal sperm count and morphology. This associa-
tion is consistent with the function of the IZUMO
protein５）. We analyzed these four SNPs by the addi-
tional primer sets. However, the SNPs were not able
to be detected. It is not clear why the sequences in-
cluding these SNPs were different between the
screening and the confirmation of SNPs. But the
specific allele in homologous chromosomes might
be amplified by effects of the setting position of the
primers because of the allele-specific modification
of DNA. The results indicated that the design of the
primer is important for analyzing SNPs. As for this
cause, a further analysis is necessary.
Recently, the four SNPs in exon 4, intron 4,
and exon 10 were identified, but they showed no sta-
tistical differences in infertile populations１１）. We
also identified the same polymorphisms in exon 4
(rs8108468) and exon 10 (rs2307018, rs2307019),
but 321C>T (rs8108468) did not result in modifica-
tion of the protein sequence and showed no signifi-
cant different in genotype frequency in the infertile
subjects in their study. The rs2307019 was linked to
rs2307018, and the minor homozygote C998T (Val
333Ala) was also not significantly different.
Until now, no study had reported on the rela-
tionships between IZUMO and male infertility. In
12 male infertile patients, a change in IZUMO ex-
pression on sperm was not detected by immunocyto-
chemistry１２）. Because we screened for variations in
the sequences coding the IZUMO protein, we may
not have found any variations that affected IZUMO
expression.
This is the first analysis of IZUMO mutations
in men with non-obstructive azoospermia. The sig-
nificant differences in genotype frequency were ob-
served to be specific to the infertile subjects in the
first screening in this study. Although the deleterious
effects of these heterozygous mutations on fertility
are unclear and may be influenced by genetic back-
ground, these SNPs were found only in the infertile
patient group.
Previously, it was reported that a dominant,
recombination-defective allele of DMC1 (DMC1mei1)
causes male-specific infertility１３）. DMC1 is a
meiosis-specific homolog of bacterial RecA and eu-
karyotic that can catalyze homologous DNA strand
invasion１４）. The DMC1mei1 mutation causes an
alanine to proline change at amino acid 272 within
the counterpart of the structurally disordered “Loop
2” of RecA for DNA binding１３）. The DMC1 null
mutation introduced infertility in both sexes by ar-
resting in meiotic prophase I１３）. When one allele of
DMC1 was expressed, no dysfunction in meiosis
was detected１５）. When DMC1mei1 was expressed
from a separate mutant allele, abnormalities were
specifically observed in male１５）. These dominant
negative autosomal mutations that affects spermio-
genesis might be transferred to the next generation
via females. Heterozygous SNPs identified in male
infertile patients may cause male infertility by alter-
ing IZUMO function.
The Cys139 was located in the region between
the signal peptide and the immunoglobulin-like do-
main , the Ser 197 was located in the
immunoglobulin-like domain, and the remaining
two significant variations were located in the C-
terminal cytoplasmic region. The substitution of Ser
197 to Cys might influence the formation of the di-
sulfide bridge (Cys182-Cys233) and result in im-
proper protein folding. In mammals, the C-terminal
sequences showed the lowest homology compared
to the N-terminus region, indicating that intracellu-
lar signaling via the IZUMO cytoplasmic region is
not a common mechanism among these species. The
Phe313Leu and Arg315Gln variations were located
in this region, but the effect of these substitutions
Shinji IRIE, Junko NAKAMURA, Akira TSUJIMURA, Yasushi MIYAGAWA, and Hiromitsu TANAKA
２１６
could not be deduced.
Our findings indicated that IZUMO might be
associated with male infertility, although not only
further investigation and functional studies of these
variants are needed to determine how the IZUMO
mutation causes infertility in human males but also
the appearance of these variations should be con-
firmed to be valid.
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要 旨
IZUMOは精子頭部の膜表面に局在し、マウスの精子と卵の受精に必須なタンパク質である。日
本人における IZUMO遺伝子の多型と精子形成の異常の関係を解析するために、我々は妊孕性の確
認されたボランティアの男性１７２人と男性不妊症患者８９２人のゲノム DNAを用いて IZUMO遺伝子
の多型と変異の検索を行った。ABI-PRISM 3730xl Genetic Analyzer and SeqScapesoftware（Applied
Biosystems社）を用い解析を行った結果、妊孕性の確認されたボランティアの男性では検出されな
い一塩基置換を男性不妊症患者に見出した。初回の探索において、男性不妊症患者に４つの一塩基
多型（４１７T>G（Cys１３９Trp），５８９A>T（Ser１９７Cys），９３９T>A（Phe３１３Leu），９４４G>A（Arg３１５Gln））が有意
に検出された。これらの一塩基置換は、別のプライマーセットを用いた塩基配列解析では検出する
ことができなかったが、一塩基多型と男性不妊症の関係の解析において重要な標的候補と考えられ
る。
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